108 related articles for article (PubMed ID: 36960749)
1. Optimization Modeling of Anti - breast Cancer Candidate Drugs.
Zhou S; Li Y; Zhang X
Biotechnol Genet Eng Rev; 2023 Mar; ():1-19. PubMed ID: 36960749
[TBL] [Abstract][Full Text] [Related]
2. A machine learning-based approach to ERα bioactivity and drug ADMET prediction.
An T; Chen Y; Chen Y; Ma L; Wang J; Zhao J
Front Genet; 2022; 13():1087273. PubMed ID: 36685926
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the Aqueous Solubility of Compounds Based on Light Gradient Boosting Machines with Molecular Fingerprints and the Cuckoo Search Algorithm.
Li M; Chen H; Zhang H; Zeng M; Chen B; Guan L
ACS Omega; 2022 Nov; 7(46):42027-42035. PubMed ID: 36440111
[TBL] [Abstract][Full Text] [Related]
4. Application of random forest based on semi-automatic parameter adjustment for optimization of anti-breast cancer drugs.
Liu J; Zhou Z; Kong S; Ma Z
Front Oncol; 2022; 12():956705. PubMed ID: 35936743
[TBL] [Abstract][Full Text] [Related]
5. A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning.
Zhang N; Pan LY; Chen WY; Ji HH; Peng GQ; Tang ZW; Wang HL; Jia YT; Gong J
Front Pharmacol; 2022; 13():896104. PubMed ID: 35847000
[TBL] [Abstract][Full Text] [Related]
6. Predicting adverse drug events in older inpatients: a machine learning study.
Hu Q; Wu B; Wu J; Xu T
Int J Clin Pharm; 2022 Dec; 44(6):1304-1311. PubMed ID: 36115909
[TBL] [Abstract][Full Text] [Related]
7. Prediction and Screening Model for Products Based on Fusion Regression and XGBoost Classification.
Wu J; Kong L; Yi M; Chen Q; Cheng Z; Zuo H; Yang Y
Comput Intell Neurosci; 2022; 2022():4987639. PubMed ID: 35958779
[TBL] [Abstract][Full Text] [Related]
8. Using a stacked ensemble learning framework to predict modulators of protein-protein interactions.
Gao M; Zhao L; Zhang Z; Wang J; Wang C
Comput Biol Med; 2023 Jul; 161():107032. PubMed ID: 37230018
[TBL] [Abstract][Full Text] [Related]
9. ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity.
Lei T; Chen F; Liu H; Sun H; Kang Y; Li D; Li Y; Hou T
Mol Pharm; 2017 Jul; 14(7):2407-2421. PubMed ID: 28595388
[TBL] [Abstract][Full Text] [Related]
10. Novel ensemble intelligence methodologies for rockburst assessment in complex and variable environments.
Li D; Liu Z; Armaghani DJ; Xiao P; Zhou J
Sci Rep; 2022 Feb; 12(1):1844. PubMed ID: 35115585
[TBL] [Abstract][Full Text] [Related]
11. Application of machine learning approaches to predict the 5-year survival status of patients with esophageal cancer.
Gong X; Zheng B; Xu G; Chen H; Chen C
J Thorac Dis; 2021 Nov; 13(11):6240-6251. PubMed ID: 34992804
[TBL] [Abstract][Full Text] [Related]
12. Optimal modeling of anti-breast cancer candidate drugs screening based on multi-model ensemble learning with imbalanced data.
Zhou J; Li X; Ma Y; Wu Z; Xie Z; Zhang Y; Wei Y
Math Biosci Eng; 2023 Jan; 20(3):5117-5134. PubMed ID: 36896538
[TBL] [Abstract][Full Text] [Related]
13. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
14. Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning.
Hu Q; Wang H; Xu T
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836131
[TBL] [Abstract][Full Text] [Related]
15. ADMETboost: a web server for accurate ADMET prediction.
Tian H; Ketkar R; Tao P
J Mol Model; 2022 Dec; 28(12):408. PubMed ID: 36454321
[TBL] [Abstract][Full Text] [Related]
16. Prediction of ADMET Properties of Anti-Breast Cancer Compounds Using Three Machine Learning Algorithms.
Li X; Tang L; Li Z; Qiu D; Yang Z; Li B
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903569
[TBL] [Abstract][Full Text] [Related]
17. Optimal Modeling of Anti-Breast Cancer Candidate Drugs Based on Graph Model Feature Selection.
Chen R; He Z; Huang S; Shen L; Zhou X
Comput Math Methods Med; 2022; 2022():8418048. PubMed ID: 36081436
[TBL] [Abstract][Full Text] [Related]
18. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.
Jiang D; Lei T; Wang Z; Shen C; Cao D; Hou T
J Cheminform; 2020 Mar; 12(1):16. PubMed ID: 33430990
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
20. Prediction of radiation-induced acute skin toxicity in breast cancer patients using data encapsulation screening and dose-gradient-based multi-region radiomics technique: A multicenter study.
Feng H; Wang H; Xu L; Ren Y; Ni Q; Yang Z; Ma S; Deng Q; Chen X; Xia B; Kuang Y; Li X
Front Oncol; 2022; 12():1017435. PubMed ID: 36439515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
